Blog articles

Gene therapy Casgevy approved for NHS use
The gene therapy Casgevy is now available on the NHS in England for people living with severe forms of beta-thalassaemia and sickle cell disease.
News articles

Dermatology joins GeNotes as 12th specialty
New dermatology collection covers a wide range of clinical scenarios, underpinned by extended opportunities for learning

GeNotes reaches 1 million page views
Our flagship resource for clinicians, GeNotes, has hit a new milestone

New in GeNotes: Gastro-Hepatology
A new collection of genomics resources for gastroenterologists and hepatologists is now available, expanding Genomics Education Programme’s flagship resource to 10 specialty areas

Visual communication aids now live on GeNotes
A set of 10 aids created for use by clinicians in consultations with patients are now available to view and download

Rare Disease Day 2025: new resources available
We have added to our range of educational resources that enable health professionals to better understand, recognise and manage rare disease
Events

Rare Disease Genomic Testing: How Do We Make Access Equitable and Timely
Progress Educational Trust (PET) present this event on making equitable rare disease genomic testing

Dravet Syndrome UK Conference
Dravet Syndrome UK presents this hybrid conference covering updates, news and medical research around Dravet syndrome

The Manchester Rare Disease Showcase
Beacon: for rare diseases presents this conference to those wanting to know more about the innovations, research and lived experiences shaping rare disease

Genomics for all: Practical family history skills for holistic care
Explore how taking a family history allows healthcare professionals to identify genetic risks, personalise care plans, and provide holistic support to patients and their families

ICED25
The ED Society hosts this in-person event for medical professionals wanting to meet other with interest in ectodermal dysplasia

The Cambridge Rare Disease Showcase
This Beacon: for rare diseases event brings together rare disease stakeholders in Cambridge


